National Institutes of Health

Description

The purpose of this NOFO is to support the Molecular Atlas of Lung Development Program (LungMAP) Phase 3 Research Centers (RCs). The overall goal of LungMAP is to build a comprehensive molecular and cellular atlas of the human lung to serve as a reference platform to better understand both normal biology and disease pathobiology, and to identify critical cellular components, molecular pathways, and novel therapeutic targets in lung disease. RCs will be expected to obtain and analyze pediatric and adult lung tissues in order to generate high-resolution molecular profiling data of the diseased lung. RCs will perform integrated data analysis, explore mechanisms of disease pathogenesis, collaborate closely with other LungMAP teams and to disseminate this resource to the broader research community. Applicants are not required to have been funded in LungMAP Phase 2 (RFA-HL-19-020) in order to submit applications to this NOFO.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH Grants Information<br/>grantsinfo@nih.gov
grantsinfo@nih.gov